Fargo biotech firm is a global leader in finding antibodies

Fargo biotech firm is a global leader in finding antibodies and turning them into new drugs


Fargo biotech firm is a global leader in finding antibodies and turning them into new drugs
Genovac, recently spun off from Aldevron, has clients in North America, Europe, Australia and Asia. The firm has technology that enables rapid antibody screening and development of drugs to fight infectious diseases, including COVID-19.
Written By: Patrick Springer
|
×
Development and production scientist Donovan McGinley-Coleman demonstrates filling the wells of a test tray in a biosafety cabinet Wednesday, April 21, 2021, at Genovac in the Batcheller Technology Center at North Dakota State University in Fargo. Michael Vosburg / Forum Photo Editor
FARGO — Genovac is a biotechnology company that specializes in discovering antibodies that can be used to make vaccines and other drugs — including antibodies that are effective in neutralizing two troublesome variants of the coronavirus.

Related Keywords

Germany , Australia , United States , North Dakota , University Of North Dakota , America , Brian Walters , Brian Kalk , Genovac Fargo , Fedex , Greater Fargo Moorhead Economic Development Corp , Technology Park , Dakota State University , Fargo Based Aldevron , North Dakota State , North America , ஜெர்மனி , ஆஸ்திரேலியா , ஒன்றுபட்டது மாநிலங்களில் , வடக்கு டகோட்டா , பல்கலைக்கழகம் ஆஃப் வடக்கு டகோட்டா , அமெரிக்கா , பிரையன் வால்டர்ஸ் , ஃபெடெக்ஸ் , அதிகமானது ஃபார்கோ மூர்ஹெட் பொருளாதார வளர்ச்சி கார்ப் , தொழில்நுட்பம் பூங்கா , டகோட்டா நிலை பல்கலைக்கழகம் , வடக்கு டகோட்டா நிலை , வடக்கு அமெரிக்கா ,

© 2025 Vimarsana